| Kandhasamy Jagathambal, MD | |
|
330 Washington St, Ste 220 Eastern Ct Hematology & Oncology, Norwich, CT 06360-2700 | |
| (860) 886-8362 | |
| (860) 886-9262 |
| Full Name | Kandhasamy Jagathambal |
|---|---|
| Gender | Female |
| Speciality | Medical Oncology |
| Experience | 58 Years |
| Location | 330 Washington St, Norwich, Connecticut |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1043295033 | NPI | - | NPPES |
| 010030513CT02 | Other | CT | BC BS |
| 0113958 | Other | CT | AETNA |
| 001305136 | Medicaid | CT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 030513 (Connecticut) | Primary |
| 207R00000X | Internal Medicine | 030513 (Connecticut) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| William W Backus Hospital | Norwich, CT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eastern Connecticut Hematology And Oncology Associates Pc | 3870552094 | 8 |
News Archive
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.
Fragile X syndrome is the most common inherited intellectual disability and the greatest single genetic contributor to autism. Unlocking the mechanisms behind fragile X could make important revelations about the brain.
Their study is the first to evaluate a smartphone app as the sole method for monitoring weight loss, with researchers creating My Meal Mate to trial against similar products for monitoring food intake, an online food diary and the traditional paper version.
› Verified 6 days ago
| Entity Name | Eastern Connecticut Hematology & Oncology Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972604338 PECOS PAC ID: 3870552094 Enrollment ID: O20041005000138 |
News Archive
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.
Fragile X syndrome is the most common inherited intellectual disability and the greatest single genetic contributor to autism. Unlocking the mechanisms behind fragile X could make important revelations about the brain.
Their study is the first to evaluate a smartphone app as the sole method for monitoring weight loss, with researchers creating My Meal Mate to trial against similar products for monitoring food intake, an online food diary and the traditional paper version.
› Verified 6 days ago
| Entity Name | Day Kimball Healthcare, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649243478 PECOS PAC ID: 5092773549 Enrollment ID: O20041229001007 |
News Archive
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.
Fragile X syndrome is the most common inherited intellectual disability and the greatest single genetic contributor to autism. Unlocking the mechanisms behind fragile X could make important revelations about the brain.
Their study is the first to evaluate a smartphone app as the sole method for monitoring weight loss, with researchers creating My Meal Mate to trial against similar products for monitoring food intake, an online food diary and the traditional paper version.
› Verified 6 days ago
| Entity Name | Day Kimball Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1376813972 PECOS PAC ID: 1557514411 Enrollment ID: O20130102000091 |
News Archive
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.
Fragile X syndrome is the most common inherited intellectual disability and the greatest single genetic contributor to autism. Unlocking the mechanisms behind fragile X could make important revelations about the brain.
Their study is the first to evaluate a smartphone app as the sole method for monitoring weight loss, with researchers creating My Meal Mate to trial against similar products for monitoring food intake, an online food diary and the traditional paper version.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Kandhasamy Jagathambal, MD 330 Washington St, Ste 220 Eastern Ct Hematology & Oncology, Norwich, CT 06360-2700 Ph: (860) 886-8362 | Kandhasamy Jagathambal, MD 330 Washington St, Ste 220 Eastern Ct Hematology & Oncology, Norwich, CT 06360-2700 Ph: (860) 886-8362 |
News Archive
Ardelyx, Inc., a clinical-stage biopharmaceutical company focused on cardio-renal, gastrointestinal, and metabolic diseases, today presented Phase 2b clinical trial results that demonstrated statistically significant and clinically meaningful improvement in IBS-C symptoms for tenapanor-treated patients compared to patients receiving placebo.
Autism is a complex neurodevelopmental disorder with no known drug treatment up until now. Researchers have finally found tweaking certain hormones could help patients with autism. There were two independent clinical trials including children and adults with autism that altered the effects of the hormone vasopressin and to assess the effects on social functioning.
Fragile X syndrome is the most common inherited intellectual disability and the greatest single genetic contributor to autism. Unlocking the mechanisms behind fragile X could make important revelations about the brain.
Their study is the first to evaluate a smartphone app as the sole method for monitoring weight loss, with researchers creating My Meal Mate to trial against similar products for monitoring food intake, an online food diary and the traditional paper version.
› Verified 6 days ago
Dr. Ting Li, M.D., PH.D., F.A.C.C Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 112 Lafayette St, Norwich, CT 06360 Phone: 860-572-5400 Fax: 860-245-0001 | |
Ankit Gupta, Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 330 Washington St Ste 430, Norwich, CT 06360 Phone: 860-886-1862 Fax: 860-886-2046 | |
Dr. Mohammed A Qureshi, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, Norwich, CT 06360 Phone: 860-889-8331 | |
Dr. Paras Satish Bhatt, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 164 Ontrobando Ave, Norwich, CT 06360 Phone: 860-889-9180 | |
Maria Sabsay Goral, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 326 Washington St, The William W.backus Hospital, Norwich, CT 06360 Phone: 860-885-6420 Fax: 860-892-6984 | |
Joselito Endaya, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1 Towne Park Plz, Norwich, CT 06360 Phone: 860-887-0010 Fax: 860-887-0178 |